Dr. Ray Takigiku, CEO of Northern Kentucky-based Bexion
Pharmaceuticals recently appeared on Fifth Third's Business Beat to
talk about his company's advancements in cancer treatment and therapy.
New funding from the Northern Kentucky ezone will help in taking these
advancements out of the lab and into the clinic where they can do the
most good for the most people.
Cancer research over the past few decades has come a long way. Now
with the help of Bexion’s unique approach to tumor therapy, that
research shows great promise for a number of cancer treatments. To see
the full video, click here.
Source: CET Connect
Writer: Jeff Syroney
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.